In cervical cancer study, β-aminopropionitrile (βAPN) inhibit LOX expression will blocked the EMT phenomenon of cervical cancer cells and inhibited invasion and migration under hypoxia in vitro; these data provide insights into the therapy and prevention of cervical cancer metastasis [38]. This evidence concerns the gene LOX and cervical carcinoma.